RT Journal Article
SR Electronic
T1 Novel Approach for Monte Carlo Simulation of the new COVID-19 Spread Dynamics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.03.20243220
DO 10.1101/2020.12.03.20243220
A1 Stavros Maltezos
A1 Angelika Georgakopoulou
YR 2020
UL http://medrxiv.org/content/early/2020/12/27/2020.12.03.20243220.abstract
AB A Monte Carlo simulation in a novel approach is used for studying the problem of the outbreak and spread dynamics of the new COVID-19 pandemic in this work. In particular, our goal was to generate epidemiological data based on natural mechanism of transmission of this disease assuming random interactions of a large-finite number of individuals in very short distance ranges. In the simulation we also take into account the stochastic character of the individuals in a finite population and given densities of people. On the other hand, we include in the simulation the appropriate statistical distributions for the parameters characterizing this disease. An important outcome of our work, besides the generated epidemic curves, is the methodology of determining of the effective reproductive number during the main part of the new daily cases of the epidemic. Since this quantity constitutes a fundamental parameter of the SIR-based epidemic models, we also studied how it is affected by small variations of the incubation time and the crucial distance distributions, and furthermore, by the degree of quarantine measures. In addition, we compare our qualitative results with those of selected real epidemiological data.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot yet registered because is a new study in this field.Funding StatementWithout any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Exemption.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data concern the parameters and applied on epidemiological data.